Logo
Homepage
Explore Our Models
My Cart
Contact
Subscribe
Models
Genetically Engineered Animals
Knockout Mice
Knockout Rats
Knockin Mice
Knockin Rats
Transgenic Mice
Transgenic Rats
Model Generation Techniques
Turboknockout<sup>®</sup> Gene Targeting
ES Cell Gene Targeting
Targeted Gene Editing
Regular Transgenic
PiggyBac Transgenesis
BAC Transgenic
Research Models
HUGO-GT™ Humanized Mice
Cre Mouse Lines
Humanized Target Gene Models
Metabolic Disease Models
Ophthalmic Disease Models
Neurological Disease Models
Autoimmune Disease Models
Immunodeficient Mouse Models
Humanized Immune System Mouse Models
Oncology & Immuno-oncology Models
Covid-19 Mouse Models
MouseAtlas Model Library
Knockout Cell Line Product Catalog
Tumor Cell Line Product Catalog
AAV Standard Product Catalog
Animal Supporting Services
Breeding Services
Cryopreservation & Recovery
Phenotyping Services
BAC Modification
Custom Cell Line Models
Induced Pluripotent Stem Cells (iPSCs)
Knockout Cell Lines
Knockin Cell Lines
Point Mutation Cell Lines
Overexpression Cell Lines
Virus Packaging
Adeno-associated Virus (AAV) Packaging
Lentivirus Packaging
Adenovirus Packaging
CRO Services
By Therapeutic Area
Oncology
Ophthalmology
Neuroscience
Metabolic & Cardiovascular Diseases
Autoimmune & Inflammatory
By Drug Type
AI-Powered AAV Discovery
Gene Therapy
Oligonucleotide Therapy
Antibody Therapy
Cell Immunotherapy
Resources
Promotion
Events & Webinars
Newsroom
Blogs & Insights
Resource Vault
Reference Databases
Peer-Reviewed Citations
Rare Disease Data Center
AbSeek
Cell iGeneEditor™ System
OriCell
Quality
Facility Overview
Animal Health & Welfare
Health Reports
About Us
Corporate Overview
Our Partners
Careers
Contact Us
Login
Request a Product Quote
Select products from our catalogs and submit your request. Our team will get back to you with detailed information.
Full Name
Email
Phone Number
Organization
Job Role
Country
Catalog Type
Product Name
Additional Comments
Cyagen values your privacy. We’d like to keep you informed about our latest offerings and insights. Your preferences:
You may unsubscribe from these communications at any time. See our Privacy Policy for details on opting out and data protection.
By clicking the button below, you consent to allow Cyagen to store and process the personal information submitted in this form to provide you the content requested.
C57BL/6NCya-Pcmtd1em1/Cya
Common Name:
Pcmtd1-KO
Product ID:
S-KO-09131
Background:
C57BL/6NCya
Product Type
Age
Genotype
Sex
Quantity
Price:
Contact for Pricing
Basic Information
Strain Name
Pcmtd1-KO
Strain ID
KOCMP-319263-Pcmtd1-B6N-VA
Gene Name
Pcmtd1
Product ID
S-KO-09131
Gene Alias
8430411F12Rik; A030012M09Rik
Background
C57BL/6NCya
NCBI ID
319263
Modification
Conventional knockout
Chromosome
1
Phenotype
MGI:2441773
Document
Click here to download >>
Application
--
More
Rare Disease Data Center >>
Note
Note: When using this mouse strain in a publication, please cite “C57BL/6NCya-Pcmtd1em1/Cya mice (Catalog S-KO-09131) were purchased from Cyagen.”
Strain Description
Ensembl Number
ENSMUST00000061280
NCBI RefSeq
NM_183028
Target Region
Exon 3
Size of Effective Region
~0.1 kb
Detailed Document
Click here to download >>
Overview of Gene Research
PCMTD1, Protein-L-isoaspartate O-Methyltransferase Domain-Containing Protein 1, contains N -terminal motifs similar to those in PCMT1 that bind l -isoaspartate and AdoMet, and a C -terminal SOCS box for ubiquitin ligase recruitment. It may act as an E3 ubiquitin ligase substrate adaptor protein, providing an alternate pathway for maintaining modified proteins in mammalian cells [3].

In a study of moyamoya disease, a p.N321S variant in PCMTD1 was initially detected in exome analysis of eight index cases but could not be confirmed by the Sanger method, suggesting it may not be a true susceptibility factor for this disease [1]. In an infant, a mesenchymal spindle cell neoplasm harbored a novel PCMTD1-PLAG1 fusion, and since PLAG1 is related to cell proliferation regulation and PCMTD1 has links to carcinoma development, this could potentially define a new group of “plagomas” [2]. Also, in genetic association studies of primary angle-closure disease (including glaucoma), SNPs in the region between PCMTD1 and ST18 (PCMTD1-ST18) have shown associations with the disease in some populations, indicating a possible role of PCMTD1 in the pathogenesis of primary angle-closure disease [4,5,6,7,8,9,10].

In summary, PCMTD1 may be involved in protein modification maintenance pathways and potentially in the development of certain tumors and primary angle-closure disease. Its study in various genetic models can help clarify its functions in normal and disease-related biological processes.

References:

1. Liu, Wanyang, Morito, Daisuke, Takashima, Seiji, Hashimoto, Nobuo, Koizumi, Akio. 2011. Identification of RNF213 as a susceptibility gene for moyamoya disease and its possible role in vascular development. In PloS one, 6, e22542. doi:10.1371/journal.pone.0022542. https://pubmed.ncbi.nlm.nih.gov/21799892/

2. Tomás-Velázquez, Alejandra, Surrey, Lea F, Miele, Evelina, Reyes-Múgica, Miguel, Salgado, Cláudia Maria. . Mesenchymal PLAG1 Tumor With PCMTD1-PLAG1 Fusion in an Infant: A New Type of "Plagoma". In The American Journal of dermatopathology, 44, 54-57. doi:10.1097/DAD.0000000000001978. https://pubmed.ncbi.nlm.nih.gov/34291746/

3. Warmack, Rebeccah A, Pang, Eric Z, Peluso, Esther, Torres, Jorge Z, Clarke, Steven G. 2022. Human Protein-l-isoaspartate O-Methyltransferase Domain-Containing Protein 1 (PCMTD1) Associates with Cullin-RING Ligase Proteins. In Biochemistry, 61, 879-894. doi:10.1021/acs.biochem.2c00130. https://pubmed.ncbi.nlm.nih.gov/35486881/

4. Sakurada, Yoichi, Mabuchi, Fumihiko. 2015. Advances in glaucoma genetics. In Progress in brain research, 220, 107-26. doi:10.1016/bs.pbr.2015.04.006. https://pubmed.ncbi.nlm.nih.gov/26497787/

5. Liang, Yu Jing, Wang, Yu Yao, Rong, Shi Song, Tham, Clement C, Chen, Li Jia. . Genetic Associations of Primary Angle-Closure Disease: A Systematic Review and Meta-Analysis. In JAMA ophthalmology, 142, 437-444. doi:10.1001/jamaophthalmol.2024.0363. https://pubmed.ncbi.nlm.nih.gov/38546604/

6. Khor, Chiea Chuen, Do, Tan, Jia, Hongyan, Wang, Ningli, Aung, Tin. 2016. Genome-wide association study identifies five new susceptibility loci for primary angle closure glaucoma. In Nature genetics, 48, 556-62. doi:10.1038/ng.3540. https://pubmed.ncbi.nlm.nih.gov/27064256/

7. Rong, Shi Song, Tang, Fang Yao, Chu, Wai Kit, Pang, Chi Pui, Chen, Li Jia. 2016. Genetic Associations of Primary Angle-Closure Disease: A Systematic Review and Meta-analysis. In Ophthalmology, 123, 1211-21. doi:10.1016/j.ophtha.2015.12.027. https://pubmed.ncbi.nlm.nih.gov/26854036/

8. Tan, Chang, Huang, Lulin, Yang, Zhenglin. . [Association of PLEKHA7, COL11A1 and PCMTD1-ST18 gene polymorphisms with primary angle closure glaucoma in ethnic Han Chinese from Sichuan]. In Zhonghua yi xue yi chuan xue za zhi = Zhonghua yixue yichuanxue zazhi = Chinese journal of medical genetics, 33, 545-9. doi:10.3760/cma.j.issn.1003-9406.2016.04.027. https://pubmed.ncbi.nlm.nih.gov/27455018/

9. Nongpiur, Monisha E, Cheng, Ching-Yu, Duvesh, Roopam, Aung, Tin, Vithana, Eranga N. 2018. Evaluation of Primary Angle-Closure Glaucoma Susceptibility Loci in Patients with Early Stages of Angle-Closure Disease. In Ophthalmology, 125, 664-670. doi:10.1016/j.ophtha.2017.11.016. https://pubmed.ncbi.nlm.nih.gov/29310965/

10. Suneel, Sangaraju, Kaliaperumal, Subashini, Kodidela, Sunitha, Goud, Alladi Charanraj, Stephen, Mary. . Ocular Biometry and Genomic Association in Primary Angle Closure Disease. A Descriptive study. In Romanian journal of ophthalmology, 68, 415-420. doi:10.22336/rjo.2024.75. https://pubmed.ncbi.nlm.nih.gov/39936063/

Quality Control Standard
Sperm Test

Pre-cryopreservation: Measurement of sperm concentration, determination of sperm viability.

Post-cryopreservation: A vial of cryopreserved sperms is selected for in-vitro fertilization from each batch.

Environmental Standards:SPF
Available Region:Global
Source:Cyagen
Model Library
Model Library
Resources
Resources
Animal Quality
Animal Quality
Get Support
Get Support
Address:
2255 Martin Avenue, Suite E Santa Clara, CA 95050-2709, US
Tel:
800-921-8930 (8-6pm PST)
+1408-963-0306 (lnt’l)
Fax:
408-969-0338
Email:
animal-service@cyagen.com
service@cyagen.us
CRO Services
OncologyOphthalmologyNeuroscienceMetabolic & CardiovascularAutoimmune & InflammatoryGene TherapyAntibody Therapy
About Us
Corporate OverviewOur PartnersCareersContact Us
Social Media
Disclaimer: Pricing and availability of our products and services vary by region. Listed prices are applicable to the specific countries. Please contact us for more information.
Copyright © 2025 Cyagen. All rights reserved.
Privacy Policy
Site Map
Stay Updated with the Latest from Cyagen
Get the latest news on our research models, CRO services, scientific resources, and special offers—tailored to your research needs and delivered straight to your inbox.
Full Name
Email
Organization
Country
Areas of Interest